semaglutide retatrutide vs. Retatrutide: A Comparison Comparing the Big 3, Semaglutide,

Obesity can increase the risk of type 2 diabetes, heart disease and certain cancers

Shanghai Municipality Science and Technology Development Fund (21JC1401600 to D.Y.)

Manufacturer Direct-to-Patient (Cash-Pay) Programs Both Novo Nordisk and Eli Lilly have launched direct-to-patient platforms offering GLP-1 medications at flat cash-pay rates significantly below the insurance list price

This article breaks down how each drug works, what trials show so far, where they differ in side effects and heart health, and how to think about choosing between them

Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia: Data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers